Acquisizione competenze di sistema:The emn2024 is an important opportunity for anyone working in the myeloma field to be informed of the latest developments and most innovative treatments for myeloma patients. New, effective clinical trials will be presented during interactive and lively sessions, with expert speakers from all over the world. The emn2024 will be a highly formative and educational event, particularly for young researchers, and also for nurses, data managers and study coordinators. also in this edition, patients’ associations will play a central role. we aim to dedicate a special session to know their perspective and expectations, and to consider their valuable suggestions for future studies. As an inclusive and open network, the emn is also committed to continuing and strengthening the collaboration with various national research groups, with key scientific societies – particularly, the european hematology association - and companies promoting new and effective clinical trials.